Jiangxi Institute of Biological Products Inc.

HK$5.83As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6915Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 19.22
TSR TTM —
Mkt cap HK$1.799B
ROIC 17.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.96
19.36%
(45.23%)
Hold 2|3|10|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.06
3.31%
7.70%
6.21%
19.50%
Revenue¥M
142.0
147.3
152.9
149.4
5.44%
9.38%
7.57%
2.70%
Peers (US$229.5M)
Cap (US$)
PE
1.100B
—
472.0M
70.32x
237.7M
155.7x
209.9M
16.81x
Capital
TTM
5Y
10Y
Leveragex
2.240
0.760
0.725
EBIT/Intx
1.607
0.471
0.358
Own earn%
49.55
172.57
196.29
Sh yield%
25.07
20.93
21.47
Owners
Insiders/Inst%
4.43
74.59
Short interest%
3.63
SBC / revenue%
2.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
8